Profound Medical Corp. reported earnings of -$ 0.21 per PROF share on Nov 5, 2026, beating analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 0.19 |
| Earnings Per Share (Surprise) | -$ 0.21 (-$ 0.02) |
| Last Year's EPS | -$ 0.35 |
| EPS YoY Change |
Out of the last 50 earnings reporting periods, Profound Medical Corp. beat analysts’ expectations 13 times and fell short of expectations 26 time(s). Profound Medical Corp. reported earnings per share of -$ 0.21 in the last report falling to reach an estimated EPS of -$ 0.19 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.19 | -$ 0.21 | -$ 0.26 | |
| Aug 6, 2026 | -$ 0.22 | -$ 0.26 | -$ 0.52 | |
| May 7, 2026 | -$ 0.24 | -$ 0.19 | -$ 0.36 | |
| Mar 5, 2026 | -$ 0.27 | -$ 0.27 | -$ 0.20 | |
| Nov 13, 2025 | -$ 0.38 | -$ 0.26 | -$ 0.38 | |
| Aug 14, 2025 | -$ 0.43 | -$ 0.52 | -$ 0.28 | |
| May 8, 2025 | -$ 0.29 | -$ 0.36 | -$ 0.26 | |
| Mar 6, 2025 | -$ 0.31 | -$ 0.20 | -$ 0.42 | |
| Nov 7, 2024 | -$ 0.30 | -$ 0.38 | -$ 0.26 | |
| Aug 8, 2024 | -$ 0.29 | -$ 0.28 | -$ 0.35 | |
| May 9, 2024 | -$ 0.30 | -$ 0.26 | -$ 0.32 | |
| Mar 7, 2024 | -$ 0.32 | -$ 0.42 | -$ 0.46 | |
| Nov 2, 2023 | -$ 0.33 | -$ 0.26 | -$ 0.24 | |
| Aug 9, 2023 | -$ 0.34 | -$ 0.35 | -$ 0.28 | |
| May 10, 2023 | -$ 0.34 | -$ 0.32 | -$ 0.40 | |
| Mar 7, 2023 | -$ 0.36 | -$ 0.46 | -$ 0.49 | |
| Nov 3, 2022 | -$ 0.38 | -$ 0.24 | -$ 0.29 | |
| Aug 4, 2022 | -$ 0.40 | -$ 0.28 | -$ 0.35 | |
| May 9, 2022 | -$ 0.43 | -$ 0.40 | -$ 0.37 | |
| Mar 3, 2022 | -$ 0.37 | -$ 0.49 | -$ 0.38 |
Profound Medical Corp.’s stock was trading at $ 7.16 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, PROF’s price increased to $ 7.21 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 0.21 | $ 7.16 | $ 7.21 | |
| Aug 6, 2026 | -$ 0.26 | $ 7.99 | $ 7.41 | |
| May 7, 2026 | -$ 0.19 | $ 7.22 | $ 6.85 | |
| Mar 5, 2026 | -$ 0.27 | $ 7.48 | $ 5.31 | |
| Nov 13, 2025 | -$ 0.26 | $ 6.47 | $ 6.85 | |
| Aug 14, 2025 | -$ 0.52 | $ 5.45 | $ 4.25 | |
| May 8, 2025 | -$ 0.36 | $ 4.81 | $ 4.63 | |
| Mar 6, 2025 | -$ 0.20 | $ 7.33 | $ 6.86 | |
| Nov 7, 2024 | -$ 0.38 | $ 8.00 | $ 8.75 | |
| Aug 8, 2024 | -$ 0.28 | $ 9.60 | $ 9.35 | |
| May 9, 2024 | -$ 0.26 | $ 7.50 | $ 7.73 | |
| Mar 7, 2024 | -$ 0.42 | $ 8.81 | $ 8.04 | |
| Nov 2, 2023 | -$ 0.26 | $ 8.48 | $ 9.60 | |
| Aug 9, 2023 | -$ 0.35 | $ 10.67 | $ 10.12 | |
| May 10, 2023 | -$ 0.32 | $ 13.14 | $ 13.71 | |
| Mar 7, 2023 | -$ 0.46 | $ 11.82 | $ 10.78 | |
| Nov 3, 2022 | -$ 0.24 | $ 3.76 | $ 4.65 | |
| Aug 4, 2022 | -$ 0.28 | $ 9.24 | $ 7.38 | |
| May 9, 2022 | -$ 0.40 | $ 7.11 | $ 6.90 | |
| Mar 3, 2022 | -$ 0.49 | $ 10.07 | $ 9.35 |
Profound Medical Corp. released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Profound Medical Corp. missed analysts’ expectations during the last earnings period by
